Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

Adjuvant chemotherapy after surgery is the standard treatment modality for stage III and part of stage II or stage IV colorectal cancer (CRC) patients. However, the 5-year overall survival (OS) rate remains unsatisfactory. Thus, developing combination therapies is essential to improve the prognosis...

詳細記述

保存先:
書誌詳細
出版年:Oncoimmunology
主要な著者: Pan, Qiu-Zhong, Zhao, Jing-Jing, Yang, Chao-Pin, Zhou, Yu-Qing, Lin, Jun-Zhong, Tang, Yan, Gu, Jia-Mei, Wang, Qi-Jing, Li, Yong-Qiang, He, Jia, Chen, Shi-Ping, Song, Meng-Jia, Huang, Yue, Yang, Jie-Ying, Weng, De-Sheng, Xia, Jian-Chuan
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185208/
https://ncbi.nlm.nih.gov/pubmed/32363125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1752563
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料